Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial

Journals

1. Murray J, Roach III M. Role of Para-aortic Radiotherapy in the Management of Prostate Cancer. Clinical Oncology 2020;32(3):189 View
2. Devos G, Witters M, Moris L, Van den Broeck T, Berghen C, Devlies W, De Meerleer G, Goffin K, Jentjens S, Albersen M, Van Poppel H, Everaerts W, Joniau S. Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by 68Ga-PSMA-11 PET/CT or 11C-Choline PET/CT: impact of postoperative treatments. World Journal of Urology 2021;39(2):399 View
3. Devos G, Berghen C, Van Eecke H, Stichele A, Van Poppel H, Goffin K, Mai C, De Wever L, Albersen M, Everaerts W, De Meerleer G, Joniau S. Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy. Cancers 2020;12(8):2271 View
4. Thiruthaneeswaran N, Hayden A, Choudhury A. The Horse is at the Stable Door: Management of N1M0 Prostate Cancer. Clinical Oncology 2020;32(3):199 View
5. De Roover R, Berghen C, De Meerleer G, Depuydt T, Crijns W. Extended field radiotherapy measurements in a single shot using a BaFBr-based OSL-film. Physics in Medicine & Biology 2019;64(16):165007 View
6. Harmon G, Chan D, Lee B, Miller C, Gorbonos A, Gupta G, Quek M, Woods M, Savir-Baruch B, Harkenrider M, Solanki A. Validating Modern NRG Oncology Pelvic Nodal and Groupe Francophone de Radiothérapie Urologique Prostate Bed Contouring Guidelines for Post-Prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial. International Journal of Radiation Oncology*Biology*Physics 2021;111(5):1195 View
7. De Meerleer G, Berghen C, Briganti A, Vulsteke C, Murray J, Joniau S, Leliveld A, Cozzarini C, Decaestecker K, Rans K, Fonteyne V, De Hertogh O, Bossi A. Elective nodal radiotherapy in prostate cancer. The Lancet Oncology 2021;22(8):e348 View
8. Van Eecke H, Devos G, Vansevenant B, Vander Stichele A, Devlies W, Berghen C, Everaerts W, De Meerleer G, Joniau S. Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy. International Journal of Urology 2023;30(1):92 View
9. Fonteyne V, Van Praet C, Ost P, Van Bruwaene S, Liefhooghe N, Berghen C, De Meerleer G, Vanneste B, Verbaeys C, Verbeke S, Lumen N. Evaluating the Impact of Prostate Only Versus Pelvic Radiotherapy for Pathological Node-positive Prostate Cancer: First Results from the Multicenter Phase 3 PROPER Trial. European Urology Focus 2023;9(2):317 View
10. Saripalli A, Lee B, Adams W, Bhandare N, Venkatesulu B, Yoo R, Price J, Harmon G, Block A, Friedman N, Harkenrider M, Major E, Small W, Wagner R, Welsh J, Solanki A. Multi-institutional Development and Validation of Contouring Guidelines for Para-aortic Elective Nodal Irradiation in Prostate Cancer Based on Patterns of Involvement on Targeted Molecular Imaging Positron Emission Tomography/Computed Tomography. International Journal of Radiation Oncology*Biology*Physics 2023;117(3):630 View
11. Murray J, De Meerleer G. How High Should We Go for Para-aortic Lymph Node Radiation Therapy?. International Journal of Radiation Oncology*Biology*Physics 2023;117(3):641 View
12. Fairweather D, Kinnaird W, Grimes H, Taylor L, Davda R, Webster A. A retrospective evaluation of inter-fraction motion in prostate cancer patients with involved nodes receiving prostate and pelvic ± para-aortic nodal irradiation. Journal of Medical Imaging and Radiation Sciences 2024;55(4):101721 View

Books/Policy Documents

1. Sharifkashani S. Radiopaedia.org. View